Literature DB >> 35972625

Screening for Fragile X Syndrome Among Filipino Children with Autism Spectrum Disorder.

Angel Belle C Dy1, Lourdes Bernadette S Tanchanco2, Jenica Clarisse Y Sy2, Myla Dominicina Levantino2, Randi J Hagerman3.   

Abstract

Individuals with autism spectrum disorder present with difficulties in social communication, restricted interests or behaviors and other co-morbidities. About 2 to 10% of cases of autism have a genetic cause, and Fragile X Syndrome (FXS) is reported in 0 to 6.5% of individuals with autism. However, the FXS and premutation prevalence among Filipino children has never been reported. The aim of the study was to establish the presence of FXS or premutation carriers among Filipino children with autism and to describe the phenotypic characteristic of cases identified. Blood was collected from 235 children aged 2-6 years old and diagnosed with autism. Samples were analyzed using PCR methods to amplify CGG repeats in the FMRI gene. The diagnosis of autism was confirmed through the Autism Diagnostic Observation Schedule-2. Additional characteristics were documented from a physical examination, Griffiths Scales of Child Development assessment and a parent-answered questionnaire using the Vineland Adaptive Behavior Scale. Fragile X testing through PCR methods in 235 children with diagnosed autism showed 220 (93.6%) were negative, no full mutations, 1 (0.436%) premutation carrier and 14 (5.95%) cases contained intermediate alleles. The FXS testing was limited to confirmed cases of autism, which is considered a high-risk group and does not provide prevalence for the general Filipino population. Subjects were self-referred or referred by clinicians, which may not represent the Filipino autism population with a bias towards those with means for clinical consultations and ability to travel to the place of testing. Samples were not measured for mosaicism, DNA methylation or AGG interspersion patterns. These may have effects on the CGG repeat expansion and overall presentation of FXS. Findings from a single premutation carrier cannot characterize features distinctly present in Filipinos with the mutation. Nevertheless, these results support the data that the prevalence of FXS in Asian populations may be lower than non-Asian populations. This can contribute to a better understanding of FXS and genetic causes of autism in the Philippines and other Asian populations.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Autism; Autism spectrum disorder; Fragile X syndrome; Genetic testing; Screening

Year:  2022        PMID: 35972625     DOI: 10.1007/s10803-022-05707-8

Source DB:  PubMed          Journal:  J Autism Dev Disord        ISSN: 0162-3257


  40 in total

1.  Increased prevalence of seizures in boys who were probands with the FMR1 premutation and co-morbid autism spectrum disorder.

Authors:  Weerasak Chonchaiya; Jacky Au; Andrea Schneider; David Hessl; Susan W Harris; Meredith Laird; Yi Mu; Flora Tassone; Danh V Nguyen; Randi J Hagerman
Journal:  Hum Genet       Date:  2011-10-15       Impact factor: 4.132

2.  Variation of the CGG repeat in FMR-1 gene in normal and fragile X Chinese subjects.

Authors:  T A Chen; X F Lu; P K Che; W K Ho
Journal:  Ann Clin Biochem       Date:  1997-09       Impact factor: 2.057

3.  Identification of fragile X pre-mutation carriers in the Chinese obstetric population using a robust FMR1 polymerase chain reaction assay: implications for screening and prenatal diagnosis.

Authors:  Y Ky Cheng; C Sw Lin; Y Ky Kwok; Y M Chan; T K Lau; T Y Leung; K W Choy
Journal:  Hong Kong Med J       Date:  2017-03-03       Impact factor: 2.227

Review 4.  Fragile X syndrome and autism at the intersection of genetic and neural networks.

Authors:  Matthew K Belmonte; Thomas Bourgeron
Journal:  Nat Neurosci       Date:  2006-10       Impact factor: 24.884

Review 5.  Autism spectrum disorder in the fragile X premutation state: possible mechanisms and implications.

Authors:  Ramkumar Aishworiya; Dragana Protic; Randi Hagerman
Journal:  J Neurol       Date:  2022-06-20       Impact factor: 6.682

6.  Fragile X syndrome: causes, diagnosis, mechanisms, and therapeutics.

Authors:  Claudia Bagni; Flora Tassone; Giovanni Neri; Randi Hagerman
Journal:  J Clin Invest       Date:  2012-12-03       Impact factor: 14.808

7.  Co-occurring conditions associated with FMR1 gene variations: findings from a national parent survey.

Authors:  Donald B Bailey; Melissa Raspa; Murrey Olmsted; David B Holiday
Journal:  Am J Med Genet A       Date:  2008-08-15       Impact factor: 2.802

8.  Incidence of fragile X syndrome by newborn screening for methylated FMR1 DNA.

Authors:  Bradford Coffee; Krayton Keith; Igor Albizua; Tamika Malone; Julie Mowrey; Stephanie L Sherman; Stephen T Warren
Journal:  Am J Hum Genet       Date:  2009-10       Impact factor: 11.025

9.  ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males.

Authors:  Leonard Abbeduto; Angela John Thurman; Andrea McDuffie; Jessica Klusek; Robyn Tempero Feigles; W Ted Brown; Danielle J Harvey; Tatyana Adayev; Giuseppe LaFauci; Carl Dobkins; Jane E Roberts
Journal:  J Autism Dev Disord       Date:  2019-03

10.  High-resolution methylation polymerase chain reaction for fragile X analysis: evidence for novel FMR1 methylation patterns undetected in Southern blot analyses.

Authors:  Liangjing Chen; Andrew Hadd; Sachin Sah; Jeffrey F Houghton; Stela Filipovic-Sadic; Wenting Zhang; Paul J Hagerman; Flora Tassone; Gary J Latham
Journal:  Genet Med       Date:  2011-06       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.